focus -WSS

focus

author：knowledge 2025-09-06 04:39:00 - browse：13

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Walmart eyes Medicare Advantage provider ChenMed

Wikipedia

WSS

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Mega Millions pot grows to $1.25 billion after no winner

NIH launches clinical trials and new research office for long Covid

New weight loss drugs vying to be the next Wegovy or Mounjaro

What the airline industry can learn from medicine

New Covid vaccine is recommended for everyone 6 months or older

knowledge

focus

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

PEPFAR is under serious threat — and so is global health

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mitch McConnell episode has important public health takeaway

How to save PrEP access — and even expand it

New weight loss drugs vying to be the next Wegovy or Mounjaro

Virginia high school admissions case could be legal follow

Long Covid needs a new name — and a new frame

Activists slam private health insurers over coverage restrictions

Infectious disease expert Jeanne Marrazzo assumes Fauci role

hotspot

New weight loss drugs vying to be the next Wegovy or Mounjaro

Private equity could exacerbate cardiology's overuse problem, experts fear

IRA could hurt research into orphan drugs for rare diseases

Food makers tried to stack nutrition panel with preferred experts

Pence says 'crackpot lawyers' told Trump what he wanted to hear

New weight loss drugs vying to be the next Wegovy or Mounjaro

hotspot

knowledge

Wikipedia

Wikipedia